Ustekinumab in Axial Spondyloarthritis

❄️ Happy February! ☃️

Our next #RheumJC will be Thursday, February 28th at 10pm Eastern Time / 9pm Central Time (click here to find this in your local time zone).

We’ll be discussing the Arthritis & Rheumatology article: Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at